Molecular Diagnostics Labs in Ghana
Engineering Excellence & Technical Support
Molecular Diagnostics Labs solutions for Clinical & Diagnostic Labs. High-standard technical execution following OEM protocols and local regulatory frameworks.
Advanced PCR & Sequencing Capabilities
Our labs are equipped with state-of-the-art Polymerase Chain Reaction (PCR) and next-generation sequencing (NGS) platforms. This enables us to perform highly sensitive and specific molecular tests for a wide range of infectious diseases (e.g., Malaria, HIV, COVID-19), genetic disorders, and pathogen identification, providing crucial diagnostic insights.
Rapid & Reliable Test Turnaround
We leverage optimized workflows and automation to deliver rapid and reliable molecular diagnostic results. Our commitment to efficiency ensures timely reporting, empowering clinicians with the information they need to make swift and effective treatment decisions, thereby improving patient outcomes.
Localized Disease Surveillance & Research
Our molecular diagnostic capabilities are instrumental in supporting localized disease surveillance programs and research initiatives across Ghana. We contribute to understanding disease prevalence, tracking outbreaks, and identifying emerging pathogens, aiding in public health strategy development and response.
What Is Molecular Diagnostics Labs In Ghana?
Molecular diagnostics laboratories in Ghana represent a critical and evolving segment of the healthcare infrastructure. These facilities leverage advanced molecular biology techniques to detect and analyze genetic material (DNA and RNA) from biological samples. This enables the identification of specific pathogens, genetic mutations, or biomarkers associated with diseases. The service involves the meticulous extraction of nucleic acids, followed by amplification (e.g., Polymerase Chain Reaction - PCR) and detection/sequencing methods to identify the presence or absence of target molecules. The precision and sensitivity of molecular diagnostics allow for early and accurate disease detection, differentiation between closely related pathogens, and characterization of genetic predispositions or treatment responses.
| Typical Use Cases of Molecular Diagnostics in Ghana | Description | Impact |
|---|---|---|
| Infectious Disease Diagnosis (e.g., COVID-19, HIV, Tuberculosis, Malaria) | Identification of pathogen-specific nucleic acids in patient samples (blood, sputum, swabs) for rapid and accurate diagnosis. | Enables timely initiation of appropriate treatment, reduces transmission, and supports outbreak control efforts. |
| Antimicrobial Resistance (AMR) Profiling | Detection of genes conferring resistance to antibiotics or antivirals in bacterial or viral pathogens. | Guides appropriate antibiotic selection, combats the spread of AMR, and preserves the efficacy of existing treatments. |
| Viral Load Monitoring (e.g., HIV, Hepatitis B/C) | Quantification of viral genetic material in the blood to assess disease progression and response to antiretroviral therapy (ART) or antiviral treatment. | Optimizes treatment regimens, prevents disease progression, and improves patient outcomes. |
| Genetic Disorder Screening (e.g., Sickle Cell Disease, Thalassemia) | Identification of specific gene mutations associated with inherited blood disorders or other genetic conditions. | Facilitates early diagnosis, genetic counseling, and informed reproductive planning. |
| Oncology - Molecular Profiling of Cancers | Analysis of tumor DNA for specific mutations (e.g., EGFR, BRAF) that predict response to targeted therapies. | Enables precision oncology, improving treatment efficacy and patient survival rates. |
| Forensic Science | DNA profiling for identification of individuals in criminal investigations or paternity testing. | Aids in justice delivery and resolves complex identification challenges. |
| Food Safety and Veterinary Diagnostics | Detection of foodborne pathogens or identification of animal diseases at a molecular level. | Ensures public health and safety in the food chain and protects livestock. |
Who Needs Molecular Diagnostics in Ghana and Why?
- Patients with Suspected Infectious Diseases: Individuals presenting with symptoms suggestive of viral (e.g., HIV, Hepatitis B/C, COVID-19, Ebola), bacterial (e.g., Tuberculosis, Malaria, Typhoid fever), or parasitic infections often require molecular testing for definitive diagnosis, especially when traditional methods are inconclusive or slow.
- Individuals Seeking Genetic Screening: Those with a family history of genetic disorders, or individuals undergoing pre-natal or new-born screening, may benefit from molecular diagnostics to identify specific genetic mutations or predispositions.
- Cancer Patients: Molecular profiling of tumors is increasingly vital for personalized cancer treatment. This includes identifying oncogenic mutations that can be targeted by specific therapies, or assessing markers for prognosis and treatment response.
- Public Health and Disease Surveillance Programs: Government health agencies and research institutions utilize molecular diagnostics for large-scale disease surveillance, outbreak investigations, tracking pathogen evolution and antimicrobial resistance, and monitoring the effectiveness of public health interventions.
- Research Institutions and Academia: For ongoing research into disease mechanisms, drug discovery, and understanding host-pathogen interactions, molecular diagnostic capabilities are indispensable.
- Blood Banks and Organ Transplantation Centers: Screening of donated blood and organs for infectious agents is a standard requirement to prevent transmission, and molecular methods offer high sensitivity for this purpose.
Who Needs Molecular Diagnostics Labs In Ghana?
Molecular diagnostics laboratories play a crucial role in Ghana's healthcare ecosystem, offering advanced testing capabilities that are vital for accurate diagnosis, effective treatment, and disease surveillance. These labs are essential for identifying infectious diseases, genetic disorders, and for guiding personalized medicine approaches. Their services extend across various sectors of the Ghanaian society, from public health initiatives to private healthcare providers and research institutions.
| Target Customer | Key Departments/Needs | Specific Applications |
|---|---|---|
| Hospitals and Clinics (Public and Private) | Infectious Disease Departments, Oncology Departments, Pediatrics, Internal Medicine, Obstetrics and Gynecology | Accurate diagnosis of viral, bacterial, and parasitic infections (e.g., HIV, Hepatitis, Malaria, Tuberculosis, COVID-19); cancer diagnostics and prognosis (e.g., HPV, EGFR mutations); prenatal screening; antibiotic resistance profiling; genetic predisposition testing. |
| Public Health Institutions (e.g., Ghana Health Service, Noguchi Memorial Institute for Medical Research) | Epidemiology and Surveillance Units, Disease Control Programs, National Reference Laboratories | Outbreak investigation and response; disease surveillance for public health monitoring; genomic sequencing for pathogen tracking and understanding transmission dynamics; development of national testing strategies; quality assurance of diagnostic tests. |
| Research and Academic Institutions | Medical Research Departments, Biology and Genetics Departments, Public Health Schools | Basic and applied research in disease mechanisms; drug discovery and development; genetic studies; clinical trials; training of future molecular diagnosticians and researchers. |
| Blood Banks and Organ Donation Centers | Transfusion Medicine, Transplantation Units | Screening of donated blood and organs for infectious agents (e.g., HIV, Hepatitis B/C, Syphilis) to ensure transfusion safety and prevent disease transmission. |
| Forensic Science Agencies | Forensic Biology Units | DNA profiling for criminal investigations, identification of victims, and paternity testing. |
| Pharmaceutical and Biotechnology Companies | Research and Development, Quality Control | Development and validation of new diagnostic kits; companion diagnostics for targeted therapies; quality control of pharmaceutical products. |
| Agricultural and Veterinary Sectors | Veterinary Diagnostic Labs, Animal Health Agencies | Diagnosis of animal diseases (e.g., Avian Influenza, African Swine Fever); food safety testing; detection of zoonotic diseases for public health protection; breeding programs. |
Who Needs Molecular Diagnostics Labs in Ghana?
- Hospitals and Clinics (Public and Private)
- Public Health Institutions
- Research and Academic Institutions
- Blood Banks and Organ Donation Centers
- Forensic Science Agencies
- Pharmaceutical and Biotechnology Companies
- Agricultural and Veterinary Sectors
Molecular Diagnostics Labs Process In Ghana
The workflow of molecular diagnostics laboratories in Ghana, from initial inquiry to the execution of tests, involves a series of structured steps designed to ensure accurate and timely results. This process is crucial for patient diagnosis, disease surveillance, and public health interventions. It begins with a referral or direct inquiry, followed by sample collection and transportation, laboratory processing, data analysis, result reporting, and finally, client communication and follow-up.
| Stage | Description | Key Activities | Responsible Personnel | Considerations/Challenges in Ghana |
|---|---|---|---|---|
| Inquiry and Test Request | The process starts when a healthcare provider (physician, nurse, public health official) or sometimes a patient directly identifies a need for molecular diagnostic testing. | Contacting the lab, discussing the clinical suspicion, understanding available tests, obtaining the correct requisition form, and clarifying pre-test requirements (e.g., fasting, specific sample type). | Healthcare Provider, Lab Receptionist/Coordinator | Awareness of available molecular tests, accessibility of laboratories, communication channels between healthcare facilities and labs. |
| Sample Collection | The appropriate biological sample is collected from the patient. | Ensuring correct sample type (blood, urine, sputum, swab, tissue, etc.), using sterile collection kits, proper labeling with patient demographics and sample details, adherence to biosafety protocols. | Healthcare Provider (e.g., Nurse, Phlebotomist), Patient (in some self-collection scenarios) | Availability of sterile collection kits, trained personnel for collection, patient education, potential for patient-induced errors if not supervised. |
| Sample Transportation and Receipt | The collected sample is transported to the molecular diagnostics laboratory under appropriate conditions. | Packaging samples in leak-proof containers, using biohazard bags, maintaining cold chain (refrigeration or frozen if required), secure transport to the lab, logging sample receipt, checking integrity and labeling. | Logistics Personnel, Lab Receptionist/Technician | Reliable transportation networks, maintenance of cold chain, timely delivery, security of samples during transit, quality control upon receipt. |
| Sample Preparation and Extraction | The biological material containing the target nucleic acid (DNA or RNA) is processed to isolate it from other cellular components. | Opening sample containers in a biosafety cabinet, performing lysis of cells/viruses, purifying nucleic acids using commercial kits or manual methods, quantification of extracted nucleic acids (optional but good practice). | Molecular Technologist/Scientist | Availability of extraction kits and reagents, appropriate laboratory space and equipment (biosafety cabinets, centrifuges, vortexers), trained personnel. |
| Molecular Amplification and Detection | The extracted nucleic acid is amplified to increase the number of target molecules, followed by detection of the amplified product. | Setting up Polymerase Chain Reaction (PCR) or other amplification assays (e.g., isothermal amplification), loading samples into instruments (e.g., real-time PCR machines, sequencers), running the amplification and detection cycles. | Molecular Technologist/Scientist | Availability of specific assay kits (e.g., for COVID-19, HIV, malaria), functional and calibrated laboratory instruments, reliable power supply, quality control reagents. |
| Data Analysis and Interpretation | The raw data generated by the instruments is analyzed to determine the presence or absence of the target analyte. | Software-based analysis of amplification curves, cycle threshold (Ct) values, melting curves (for some assays), comparison with positive and negative controls, interpretation of results based on established cut-offs. | Molecular Technologist/Scientist, Laboratory Manager/Supervisor | Availability of analysis software, consistent interpretation guidelines, staff expertise in data analysis, potential for instrument malfunction affecting data quality. |
| Result Reporting | The interpreted results are compiled into a formal report for the requesting healthcare provider or relevant authority. | Generating a laboratory report with patient demographics, test performed, result (positive, negative, indeterminate, or quantitative value), date of report, signature of reporting officer, and any relevant comments or recommendations. | Laboratory Manager/Supervisor, Reporting Officer | Standardized reporting formats, efficient report generation and delivery mechanisms (e.g., electronic or hard copy), ensuring confidentiality. |
| Client Communication and Follow-up | The results are communicated to the requester, and sometimes follow-up actions are initiated. | Delivering reports to healthcare providers, discussing results and their implications, providing guidance on next steps (e.g., treatment, further investigation), contributing to disease surveillance data, and providing feedback to the lab on the utility of results. | Laboratory Manager/Supervisor, Clinician | Effective communication channels, timely dissemination of critical results, mechanisms for feedback and continuous improvement. |
Molecular Diagnostics Lab Process in Ghana: Workflow Stages
- Inquiry and Test Request
- Sample Collection
- Sample Transportation and Receipt
- Sample Preparation and Extraction
- Molecular Amplification and Detection
- Data Analysis and Interpretation
- Result Reporting
- Client Communication and Follow-up
Molecular Diagnostics Labs Cost In Ghana
The cost of molecular diagnostics in Ghana can vary significantly due to a number of factors, making it challenging to provide a single definitive price. These factors include the specific test being performed, the type of laboratory (public vs. private, large vs. small), the reagents and equipment used, the geographic location within Ghana, and the demand for the particular diagnostic service. Generally, molecular diagnostic tests, which often involve complex processes like PCR (Polymerase Chain Reaction) or sequencing, are more expensive than standard blood tests or urine analyses. The price is also influenced by the overhead costs of the laboratory, including skilled personnel, maintenance of sophisticated equipment, and the procurement of specialized consumables. The Ghanaian Cedi (GHS) is the local currency used for these services.
| Type of Molecular Test (Example) | Estimated Price Range (GHS) | Notes |
|---|---|---|
| COVID-19 PCR Test | 150 - 400 | Prices can vary significantly between public and private facilities, and may be influenced by government directives or special campaigns. |
| Hepatitis B Viral Load | 250 - 500 | Often performed in larger hospitals and specialized labs. Consumable costs play a role. |
| HIV Viral Load | 280 - 550 | Similar to Hepatitis B, this test requires sophisticated equipment and specialized reagents. |
| Malaria Parasite Detection (PCR) | 200 - 450 | More sensitive than microscopy, often used in research or for confirmation of difficult cases. |
| Basic Genetic Testing (e.g., Carrier Screening for specific diseases) | 500 - 1500+ | These tests can be highly specialized and depend on the number of genes being analyzed. Often require sending samples abroad for certain analyses. |
| Tuberculosis (TB) GeneXpert Test | 180 - 350 | Widely used for TB diagnosis, particularly in public health settings. |
Key Pricing Factors for Molecular Diagnostics in Ghana
- Type of Test: Different molecular tests (e.g., viral load, genetic testing, pathogen identification) require varying levels of complexity and specialized reagents, directly impacting cost.
- Laboratory Type & Ownership: Private laboratories typically have higher operational costs and therefore charge more than public or government-funded institutions, which may receive subsidies.
- Reagent and Consumable Costs: The availability and cost of imported reagents, enzymes, and plasticware can fluctuate, influencing the final price.
- Equipment Sophistication and Maintenance: Advanced molecular diagnostic equipment requires significant investment and ongoing maintenance, contributing to laboratory expenses.
- Personnel Expertise: Highly skilled scientists and technicians are essential for accurate molecular diagnostics, and their salaries form a substantial part of the cost.
- Geographic Location: Costs might be slightly higher in major urban centers like Accra due to higher operational expenses and demand, compared to more rural areas.
- Demand and Volume: Higher demand for specific tests can sometimes lead to economies of scale, potentially reducing per-test costs, while low demand can increase them.
- Accreditation and Quality Standards: Laboratories adhering to international quality standards may incur higher costs associated with their accreditation processes.
Affordable Molecular Diagnostics Labs Options
Access to affordable molecular diagnostics labs is crucial for timely and accurate disease detection and management. These labs play a vital role in identifying pathogens, genetic mutations, and biomarkers, enabling personalized treatment and preventative healthcare. The cost of molecular diagnostics can be a barrier for many individuals and healthcare systems. Therefore, exploring options that offer value bundles and implementing cost-saving strategies is essential to improve accessibility and sustainability.
Value Bundles in molecular diagnostics refer to packages of tests or services offered together at a reduced price compared to purchasing them individually. These bundles are designed to cater to specific clinical needs, patient populations, or diagnostic workflows, providing a more comprehensive and cost-effective solution. For instance, a bundle might include a panel of tests for a particular infectious disease syndrome, a set of genetic tests for a hereditary condition, or routine screening panels bundled with follow-up diagnostic tests. The rationale behind value bundles is to encourage broader utilization of essential diagnostic tools, streamline testing processes, and leverage economies of scale for the laboratory.
Cost-Saving Strategies are multifaceted approaches employed by laboratories, healthcare providers, and even patients to reduce the overall expenditure associated with molecular diagnostics. These strategies can encompass procurement, operational efficiency, utilization management, and technological advancements. By implementing a combination of these strategies, the aim is to make molecular diagnostics more financially accessible without compromising on accuracy or quality. This includes negotiating bulk purchasing agreements, optimizing reagent usage, implementing automation, leveraging economies of scale, and exploring tiered pricing models.
| Value Bundle Type | Description | Benefits | Cost-Saving Aspect |
|---|---|---|---|
| Syndromic Panels | Bundled tests for common symptom clusters (e.g., respiratory, gastrointestinal, sepsis). | Faster diagnosis, targeted treatment, reduced unnecessary testing. | Lower per-test cost, efficient workflow. |
| Hereditary Condition Panels | Group of genetic tests for specific inherited diseases (e.g., cancer predisposition, cardiovascular risks). | Comprehensive risk assessment, proactive management, family screening. | Reduced cost compared to individual gene analysis. |
| Antimicrobial Resistance (AMR) Panels | Tests identifying resistance genes in pathogens. | Appropriate antibiotic selection, improved patient outcomes, reduced healthcare costs. | Streamlined testing, avoids trial-and-error antibiotic use. |
| Pharmacogenomics (PGx) Bundles | Tests predicting drug response based on genetic makeup. | Personalized medication selection, optimized dosing, reduced adverse drug reactions. | Long-term cost savings by avoiding ineffective treatments. |
| Comprehensive Screening Bundles | Routine tests for common health concerns (e.g., STD panels, infectious disease screenings). | Early detection, preventative care, population health management. | Economies of scale, encourages regular testing. |
Key Considerations for Affordable Molecular Diagnostics Labs
- Understanding the different types of molecular diagnostic tests and their applications.
- Identifying reputable labs that offer competitive pricing and reliable results.
- Exploring government programs, insurance coverage, and patient assistance initiatives.
- Advocating for policies that support affordable access to diagnostic services.
- Staying informed about technological advancements that may reduce testing costs.
Verified Providers In Ghana
In Ghana, ensuring you receive healthcare from verified providers is paramount for your well-being. Franance Health stands out as a leader in this space, offering a rigorous credentialing process that guarantees the competence and reliability of its network. This commitment to quality means that when you choose a Franance Health-affiliated provider, you are opting for a healthcare professional who has met stringent standards, ensuring you receive safe, effective, and ethical medical care. Their comprehensive vetting goes beyond basic qualifications, encompassing a deep dive into experience, ongoing professional development, and adherence to best practices. This meticulous approach provides unparalleled peace of mind, making Franance Health the superior choice for accessing trusted medical expertise in Ghana.
| Provider Type | Franance Health Verification Benefit | Why it Matters to You |
|---|---|---|
| General Practitioners | Verified by Franance Health for foundational medical knowledge and patient care protocols. | Ensures you receive accurate diagnoses and effective primary treatment for common ailments. |
| Specialist Physicians (e.g., Cardiologists, Dermatologists) | Franance Health confirms specialized training, board certifications, and extensive experience in their respective fields. | Guarantees access to highly qualified experts for complex health conditions and advanced treatments. |
| Surgeons | Rigorous verification of surgical skills, operative experience, and adherence to sterile techniques and post-operative care standards. | Provides confidence in the safety and success of surgical procedures. |
| Dentists | Franance Health ensures qualifications, licensing, and a commitment to oral hygiene best practices. | Offers reliable dental care for a healthy smile and overall well-being. |
| Nurses and Allied Health Professionals | Verification of professional qualifications, certifications, and a dedication to patient support and care. | Ensures competent and compassionate support throughout your healthcare journey. |
Key Credentials Verified by Franance Health
- Medical license verification from the Medical and Dental Council of Ghana.
- Proof of advanced academic degrees and specialized training.
- Verification of professional experience and practice history.
- Confirmation of malpractice insurance and a clean disciplinary record.
- Adherence to Franance Health's stringent ethical guidelines and patient care standards.
Scope Of Work For Molecular Diagnostics Labs
This document outlines the Scope of Work (SOW) for Molecular Diagnostics Laboratories, detailing essential technical deliverables and standard specifications. It aims to provide a comprehensive framework for laboratory operations, ensuring accuracy, reliability, and adherence to regulatory requirements.
| Technical Deliverable | Standard Specifications/Description | Key Performance Indicators (KPIs) |
|---|---|---|
| Sample Integrity and Tracking | Specimens must be received, logged, and stored under conditions that maintain nucleic acid integrity. Unique identifiers must be assigned and tracked throughout the entire workflow. | Sample rejection rate (< 1%); Turnaround time (TAT) for sample receipt to processing start (< 4 hours) |
| Nucleic Acid Extraction Efficiency | High yield and purity of DNA/RNA extracted, suitable for downstream amplification. Validated extraction kits or in-house protocols must be used. | Average nucleic acid yield (ng/µL); A260/A280 ratio (1.8-2.0); A260/A230 ratio (2.0-2.2) |
| Amplification Sensitivity and Specificity | Detection of target nucleic acid sequences with high sensitivity and specificity, minimizing false positives and negatives. Validated assay protocols and appropriate controls are mandatory. | Limit of Detection (LoD) for target analytes; Analytical specificity (no cross-reactivity with non-target sequences); Assay concordance with reference methods (>98%) |
| Quantitative Accuracy (where applicable) | Accurate and reproducible quantification of target nucleic acid load (e.g., viral load, gene copy number). Calibration curves must be established and verified. | Coefficient of variation (CV) for quantitative results (< 15%); Accuracy against known standards |
| Data Analysis and Interpretation | Automated and manual review of raw data for accuracy and validity. Interpretation based on established clinical guidelines and laboratory SOPs. | Rate of data re-analysis requests (< 2%); Concordance between independent data reviewers |
| Quality Control (QC) Performance | Routine inclusion of positive, negative, and inhibition controls in each run. QC results must fall within predefined acceptance criteria. | Percentage of runs with valid QC results (>99%); Mean and standard deviation of QC signals |
| Instrument Performance and Calibration | Regular calibration, maintenance, and performance verification of all molecular diagnostic instrumentation (e.g., PCR thermocyclers, sequencers, automated extractors). | Instrument uptime (>95%); Calibration and maintenance records up-to-date; Performance verification within manufacturer specifications |
| Reagent Lot-to-Lot Consistency | Verification of reagent performance for each new lot. Consistent results across different reagent lots are essential. | Lot validation success rate (>98%); No significant deviation in QC results between lots |
| Turnaround Time (TAT) | Timely processing of samples and delivery of accurate results within established TAT targets for different assay types. | TAT adherence for routine tests (>90%); TAT adherence for STAT tests (>95%) |
| Reporting Accuracy and Completeness | Clear, concise, and accurate reporting of results, including interpretive comments when necessary. Reports must be reviewed and approved by qualified personnel. | Error rate in reports (< 0.1%); Completeness of reports according to regulatory requirements |
| Biosafety Compliance | Adherence to all relevant biosafety guidelines (e.g., BSL-2 or higher) for handling potentially infectious materials. Proper waste disposal protocols. | No biosafety incidents; Successful completion of biosafety audits |
| Information System Reliability | Secure and reliable Laboratory Information Management System (LIMS) for sample tracking, data management, and reporting. | LIMS uptime (>99.5%); Data integrity checks passed |
Key Areas of Molecular Diagnostics Laboratory Operations
- Sample Receipt and Handling
- Nucleic Acid Extraction and Purification
- Amplification and Detection Methods
- Data Analysis and Interpretation
- Quality Assurance and Quality Control (QA/QC)
- Reporting and Documentation
- Instrument Maintenance and Calibration
- Reagent Management
- Biosafety and Biosecurity
- Information Technology and Data Management
Service Level Agreement For Molecular Diagnostics Labs
This Service Level Agreement (SLA) outlines the expected response times and uptime guarantees for molecular diagnostic laboratory services provided by [Your Lab Name] to [Client Name]. This SLA is designed to ensure timely and reliable delivery of diagnostic results, crucial for patient care and clinical decision-making.
| Service Category | Metric | Target | Definition | Notes/Exceptions |
|---|---|---|---|---|
| Operational Availability | Uptime | 99.5% | Percentage of scheduled operating hours that laboratory systems are functional and accessible. | Excludes scheduled maintenance, force majeure events, and client-initiated delays. |
| Sample Turnaround Time (TAT) | Sample Receipt to Initial Processing | 24 Business Hours | Time from sample logged in LIMS to start of extraction/isolation. | Applies to routine tests. May vary for complex assays or high sample volumes. See Appendix A for specific test TATs. |
| Sample Turnaround Time (TAT) | Result Reporting (Post-Initial Processing) | 48 Business Hours | Time from completion of analytical steps to result release in LIMS. | Applies to routine tests. Excludes time for confirmatory testing or external reference lab analysis. See Appendix A for specific test TATs. |
| Critical Sample Handling | Critical Sample TAT | 12 Business Hours | Total time from receipt to reporting for samples explicitly marked as critical. | Requires clear client communication and pre-arranged critical sample protocols. |
| System Maintenance | Scheduled Downtime | Maximum 4 hours per month | Planned periods for essential system updates and maintenance. | Notification provided at least 7 days in advance. Typically scheduled outside of peak operating hours. |
Key Service Metrics
- Uptime Guarantee: The laboratory's operational systems, including instrumentation, LIMS, and connectivity, will be available at least 99.5% of the time during scheduled operating hours.
- Response Time - Sample Receipt to Initial Processing: The time from when a sample is received and logged into the Laboratory Information Management System (LIMS) to the initiation of the first analytical step (e.g., DNA extraction, RNA isolation).
- Response Time - Result Reporting: The time from the completion of all necessary analytical steps and quality control checks to the final reporting of results to the authorized recipient.
- Critical Sample Prioritization: Procedures and associated response times for samples designated as urgent or critical.
- System Maintenance: Planned downtime for essential system maintenance will be communicated in advance.
- Downtime Notification: Procedures for notifying the client in case of unscheduled downtime.
Frequently Asked Questions
Ready when you are
Let's scope your Molecular Diagnostics Labs in Ghana project in Ghana.
Scaling healthcare logistics and technical systems across the entire continent.